Viewing Study NCT06508658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT06508658
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2024-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Genmab
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epcoritamab View
None Lenalidomide View
None Rituximab View
None Gemcitabine View
None Oxaliplatin View
None Diffuse Large B-Cell Lymphoma View
None DLBCL View
None Epkinly View
None ABBV-GMAB-3013 View